Inventor
AFAR DANIEL E H
US58 patents
⚠️ This page may combine multiple inventors who share the name “AFAR DANIEL E H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGENSYS INC
47 patentsUS7507541B2Mar 24, 2009
36P6D5: secreted tumor antigen
AGENSYS INC89 citations98
US7166714B2Jan 23, 2007
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC35 citations96
US7641905B2Jan 5, 2010
Methods of inducing an immune response
AGENSYS INC25 citations93
US7628989B2Dec 8, 2009
Methods of inducing an immune response
AGENSYS INC23 citations93
US6602501B1Aug 5, 2003
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
AGENSYS INC13 citations93
US7947459B2May 24, 2011
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC19 citations92
US7510840B1Mar 31, 2009
Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody
AGENSYS INC16 citations92
US7459539B2Dec 2, 2008
Antibody that binds zinc transporter protein 108P5H8
AGENSYS INC16 citations92
US7455991B2Nov 25, 2008
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC14 citations92
US7223542B2May 29, 2007
36P6D5: secreted tumor antigen
AGENSYS INC13 citations92
US7037667B1May 2, 2006
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
AGENSYS INC41 citations92
US6893818B1May 17, 2005
Gene upregulated in cancers of the prostate
AGENSYS INC19 citations92
US7795391B2Sep 14, 2010
Protein showing enhanced expression in cancer cells
AGENSYS INC8 citations84
US6566078B1May 20, 2003
36P6D5: secreted tumor antigen
AGENSYS INC12 citations82
US7227008B2Jun 5, 2007
13-transmembrane protein expressed in prostate cancer
AGENSYS INC5 citations74
US6924358B2Aug 2, 2005
121P1F1: a tissue specific protein highly expressed in various cancers
AGENSYS INC5 citations74
US6835822B1Dec 28, 2004
Diagnosis and therapy of cancer using SGP28-related molecules
AGENSYS INC7 citations74
US7928212B2Apr 19, 2011
Gene upregulated in cancers of the prostate
AGENSYS INC1 citations63
US7771968B2Aug 10, 2010
Gene upregulated in cancers of the prostate
AGENSYS INC2 citations63
US7736654B2Jun 15, 2010
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
AGENSYS INC1 citations63
US7569356B2Aug 4, 2009
Diagnosis and therapy of cancer using SGP28-related molecules
AGENSYS INC1 citations63
US7488479B2Feb 10, 2009
Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
AGENSYS INC1 citations63
US7351583B2Apr 1, 2008
Antibodies to G protein-coupled receptor
AGENSYS INC1 citations63
US7271240B2Sep 18, 2007
125P5C8: a tissue specific protein highly expressed in various cancers
AGENSYS INC2 citations63
US7153940B2Dec 26, 2006
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
AGENSYS INC1 citations63
US7087718B2Aug 8, 2006
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
AGENSYS INC1 citations63
US6838258B2Jan 4, 2005
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
AGENSYS INC1 citations63
US6790631B1Sep 14, 2004
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
AGENSYS INC1 citations63
US7601825B2Oct 13, 2009
Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
AGENSYS INC3 citations61
US6863892B2Mar 8, 2005
Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
AGENSYS INC5 citations60
US8039000B2Oct 18, 2011
Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
AGENSYS INC0 citations52
US8039603B2Oct 18, 2011
Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
AGENSYS INC0 citations52
US8022174B2Sep 20, 2011
C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof
AGENSYS INC0 citations52
US7968283B2Jun 28, 2011
Gene expressed in prostate cancer
AGENSYS INC0 citations52
US7951375B2May 31, 2011
Methods of inducing an immune response
AGENSYS INC0 citations52
US7928196B2Apr 19, 2011
Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
AGENSYS INC0 citations52
US7897740B2Mar 1, 2011
Secreted protein called 36P6D5 characteristic of tumors
AGENSYS INC0 citations52
US7892548B2Feb 22, 2011
121P1F1: a tissue specific protein highly expressed in various cancers
AGENSYS INC0 citations52
US7858760B2Dec 28, 2010
Antibodies to protein expressed in prostate cancer
AGENSYS INC0 citations52
US7834156B2Nov 16, 2010
125P5C8: tissue specific protein highly expressed in various cancers
AGENSYS INC0 citations52
US7759474B2Jul 20, 2010
Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
AGENSYS INC0 citations52
US7598045B2Oct 6, 2009
C-type LECTIN transmembrane antigen expressed in human prostate cancer and uses thereof
AGENSYS INC0 citations52
US7309585B2Dec 18, 2007
121P1F1: a tissue specific protein highly expressed in various cancers
AGENSYS INC0 citations52
US7208280B2Apr 24, 2007
Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
AGENSYS INC1 citations52
US7148337B2Dec 12, 2006
C-type LECTIN transmembrane antigen expressed in human prostate cancer and uses thereof
AGENSYS INC0 citations52
US8013126B2Sep 6, 2011
84P2A9: a prostate and testis specific protein highly expressed in prostate cancer
AGENSYS INC0 citations51
US7981624B2Jul 19, 2011
Methods to detect tumors using 20P1F12/TMPRSS2 expression
AGENSYS INC0 citations51
ABBVIE BIOTHERAPEUTICS INC
1 patentHUBERT RENE S
1 patentCEDARS SINAI MEDICAL CENTER
1 patentShowing the top 50 of 58 patents by PatentIndex Score.